Nurix Therapeutics Stock Options Expiring on 21st of February
| NRIX Stock | USD 20.10 0.96 5.02% |
Nurix Therapeutics' latest option contracts expiring on February 21st 2025 are carrying combined implied volatility of 1.78 with a put-to-call open interest ratio of 0.01 over 20 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on February 21st 2025.
Open Interest Against February 21st 2025 Option Contracts
Nurix Therapeutics option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Nurix Therapeutics' lending market. For example, when Nurix Therapeutics' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Nurix Therapeutics, he or she must hedge the risk by shorting Nurix Therapeutics stock over its option's life.
2025-02-21
The chart above shows Nurix Therapeutics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Nurix Therapeutics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Nurix Therapeutics' option, there is no secondary market available for investors to trade.
Nurix Therapeutics In The Money Call Balance
When Nurix Therapeutics' strike price is surpassing the current stock price, the option contract against Nurix Therapeutics stock is said to be in the money. When it comes to buying Nurix Therapeutics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Nurix Therapeutics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Nurix Current Options Market Mood
Nurix Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Nurix Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Nurix Therapeutics' options investors are not very successful. Nurix Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Nurix contract
Base on the Rule 16, the options market is currently suggesting that Nurix Therapeutics will have an average daily up or down price movement of about 0.11% per day over the life of the 2025-02-21 option contract. With Nurix Therapeutics trading at USD 20.1, that is roughly USD 0.0224. If you think that the market is fully incorporating Nurix Therapeutics' daily price movement you should consider buying Nurix Therapeutics options at the current volatility level of 1.78%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Nurix |
Nurix Therapeutics Option Chain
When Nurix Therapeutics' strike price is surpassing the current stock price, the option contract against Nurix Therapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Nurix Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Nurix. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Nurix. It also shows strike prices and maturity days for a Nurix Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | NRIX250221C00007500 | 0 | 7.5 | 9.9 - 13.3 | 9.9 | In |
Call | NRIX250221C00010000 | 0 | 10.0 | 8.1 - 11.0 | 8.1 | In |
Call | NRIX250221C00012500 | 1 | 12.5 | 5.4 - 8.1 | 7.5 | In |
Call | NRIX250221C00015000 | 0 | 15.0 | 3.5 - 6.2 | 3.5 | In |
Call | NRIX250221C00017500 | 4 | 17.5 | 1.85 - 4.1 | 2.94 | In |
Call | NRIX250221C00020000 | 17 | 20.0 | 0.8 - 2.05 | 1.72 | Out |
Call | NRIX250221C00022500 | 274 | 22.5 | 0.2 - 0.85 | 0.7 | Out |
Call | NRIX250221C00025000 | 122 | 25.0 | 0.05 - 0.8 | 0.3 | Out |
Call | NRIX250221C00030000 | 0 | 30.0 | 0.05 - 4.9 | 0.05 | |
Call | NRIX250221C00035000 | 0 | 35.0 | 0.0 - 4.9 | 4.9 | |
Put | NRIX250221P00007500 | 0 | 7.5 | 0.0 - 4.9 | 4.9 | |
Put | NRIX250221P00010000 | 0 | 10.0 | 0.0 - 4.9 | 4.9 | |
Put | NRIX250221P00012500 | 0 | 12.5 | 0.0 - 4.9 | 4.9 | |
Put | NRIX250221P00015000 | 2 | 15.0 | 0.0 - 4.8 | 0.75 | Out |
Put | NRIX250221P00017500 | 0 | 17.5 | 0.4 - 2.35 | 0.4 | |
Put | NRIX250221P00020000 | 0 | 20.0 | 1.65 - 3.2 | 1.65 | In |
Put | NRIX250221P00022500 | 1 | 22.5 | 3.4 - 5.0 | 4.1 | In |
Put | NRIX250221P00025000 | 1 | 25.0 | 5.4 - 7.3 | 6.5 | In |
Put | NRIX250221P00030000 | 0 | 30.0 | 9.4 - 12.1 | 9.4 | In |
Put | NRIX250221P00035000 | 0 | 35.0 | 14.8 - 17.4 | 14.8 | In |
Nurix Therapeutics Market Cap Over Time
Market Cap |
| Timeline |
Nurix Total Stockholder Equity
Total Stockholder Equity |
|
Nurix Therapeutics Corporate Management
| Stefani Wolff | COO Devel | Profile | |
| Christine JD | Secretary Officer | Profile | |
| John Kuriyan | Founder Board | Profile | |
| JD Esq | VP Counsel | Profile | |
| Cristiana Guiducci | Senior Research | Profile | |
| Pasit Phiasivongsa | Chief Officer | Profile |
Additional Tools for Nurix Stock Analysis
When running Nurix Therapeutics' price analysis, check to measure Nurix Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nurix Therapeutics is operating at the current time. Most of Nurix Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nurix Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nurix Therapeutics' price. Additionally, you may evaluate how the addition of Nurix Therapeutics to your portfolios can decrease your overall portfolio volatility.